Yang, Li
Xiong, RongFei
Chen, XingQu
Wang, Shu
Yu, DeShui
Funding for this research was provided by:
Sichuan Provincial Science and Technology Department (2022NSFSC0709, 2022NSFSC0709, 2022NSFSC0709)
Article History
Received: 23 January 2024
Accepted: 17 May 2024
First Online: 25 May 2024
Declarations
:
: This research was approved by the Ethics Committee of The Second People’s Hospital of Yibin City (ClinicalTrials.gov Identifier: 2019–015-01).Informed consent is signed by all participants. Our study followed the Criterions for the Quality Control of Clinical Trial of drugs.
: Not applicable.
: The authors declare no competing interests.